These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25625028)

  • 1. Assessment of vulnerable atherosclerotic and fibrotic plaques in coronary arteries using (68)Ga-DOTATATE PET/CT.
    Mojtahedi A; Alavi A; Thamake S; Amerinia R; Ranganathan D; Tworowska I; Delpassand ES
    Am J Nucl Med Mol Imaging; 2015; 5(1):65-71. PubMed ID: 25625028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 68Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with18F-FDG, calcium burden and risk factors.
    Li X; Samnick S; Lapa C; Israel I; Buck AK; Kreissl MC; Bauer W
    EJNMMI Res; 2012 Sep; 2(1):52. PubMed ID: 23016793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 64Cu-DOTATATE for Noninvasive Assessment of Atherosclerosis in Large Arteries and Its Correlation with Risk Factors: Head-to-Head Comparison with 68Ga-DOTATOC in 60 Patients.
    Malmberg C; Ripa RS; Johnbeck CB; Knigge U; Langer SW; Mortensen J; Oturai P; Loft A; Hag AM; Kjær A
    J Nucl Med; 2015 Dec; 56(12):1895-900. PubMed ID: 26429961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Atherosclerotic Inflammation by
    Tarkin JM; Joshi FR; Evans NR; Chowdhury MM; Figg NL; Shah AV; Starks LT; Martin-Garrido A; Manavaki R; Yu E; Kuc RE; Grassi L; Kreuzhuber R; Kostadima MA; Frontini M; Kirkpatrick PJ; Coughlin PA; Gopalan D; Fryer TD; Buscombe JR; Groves AM; Ouwehand WH; Bennett MR; Warburton EA; Davenport AP; Rudd JH
    J Am Coll Cardiol; 2017 Apr; 69(14):1774-1791. PubMed ID: 28385306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET/CT Imaging of Unstable Carotid Plaque with
    Wan MYS; Endozo R; Michopoulou S; Shortman R; Rodriguez-Justo M; Menezes L; Yusuf S; Richards T; Wild D; Waser B; Reubi JC; Groves A
    J Nucl Med; 2017 May; 58(5):774-780. PubMed ID: 27932558
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of Somatostatin Receptor 2-Targeting PET Tracers in the Detection of Mouse Atherosclerotic Plaques.
    Rinne P; Hellberg S; Kiugel M; Virta J; Li XG; Käkelä M; Helariutta K; Luoto P; Liljenbäck H; Hakovirta H; Gardberg M; Airaksinen AJ; Knuuti J; Saraste A; Roivainen A
    Mol Imaging Biol; 2016 Feb; 18(1):99-108. PubMed ID: 26122428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific somatostatin receptor II expression in arterial plaque: (68)Ga-DOTATATE autoradiographic, immunohistochemical and flow cytometric studies in apoE-deficient mice.
    Li X; Bauer W; Kreissl MC; Weirather J; Bauer E; Israel I; Richter D; Riehl G; Buck A; Samnick S
    Atherosclerosis; 2013 Sep; 230(1):33-9. PubMed ID: 23958249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-axial field-of-view PET/CT for the assessment of inflammation in calcified coronary artery plaques with [
    Mingels C; Sari H; Gözlügöl N; Bregenzer C; Knappe L; Krieger K; Afshar-Oromieh A; Pyka T; Nardo L; Gräni C; Alberts I; Rominger A; Caobelli F
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):422-433. PubMed ID: 37740742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification.
    Velikyan I; Sundin A; Sörensen J; Lubberink M; Sandström M; Garske-Román U; Lundqvist H; Granberg D; Eriksson B
    J Nucl Med; 2014 Feb; 55(2):204-10. PubMed ID: 24379222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo imaging of macrophage activity in the coronary arteries using 68Ga-DOTATATE PET/CT: correlation with coronary calcium burden and risk factors.
    Rominger A; Saam T; Vogl E; Ubleis C; la Fougère C; Förster S; Haug A; Cumming P; Reiser MF; Nikolaou K; Bartenstein P; Hacker M
    J Nucl Med; 2010 Feb; 51(2):193-7. PubMed ID: 20080898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
    Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
    J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordance Between Histopathologic Grading and Dual-Tracer PET/CT Findings in Metastatic NETs and Outcome of
    Adnan A; Basu S
    J Nucl Med Technol; 2022 Sep; 50(3):248-255. PubMed ID: 34876476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting vulnerable atherosclerotic plaque via PET-tracers aiming at cell-surface overexpression of somatostatin receptors.
    Z Papadakis G; Kochiadakis G; Lazopoulos G; Marias K; Klapsinos N; Hannah-Shmouni F; G Igoumenaki G; Konstantinos Nikolouzakis T; Kteniadakis S; A Spandidos D; H Karantanas A
    Biomed Rep; 2020 Sep; 13(3):9. PubMed ID: 32765848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
    Sampathirao N; Basu S
    J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 64Cu-DOTATATE PET/MRI for Detection of Activated Macrophages in Carotid Atherosclerotic Plaques: Studies in Patients Undergoing Endarterectomy.
    Pedersen SF; Sandholt BV; Keller SH; Hansen AE; Clemmensen AE; Sillesen H; Højgaard L; Ripa RS; Kjær A
    Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1696-703. PubMed ID: 25977567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of somatostatin receptor expressing tumor volume calculated from
    Toriihara A; Baratto L; Nobashi T; Park S; Hatami N; Davidzon G; Kunz PL; Iagaru A
    Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2244-2251. PubMed ID: 31350603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-to-Blood Ratio for Assessment of Somatostatin Receptor Density in Neuroendocrine Tumors Using
    Ilan E; Velikyan I; Sandström M; Sundin A; Lubberink M
    J Nucl Med; 2020 Feb; 61(2):217-221. PubMed ID: 31302632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin receptor imaging in non-(131)I-avid metastatic differentiated thyroid carcinoma for determining the feasibility of peptide receptor radionuclide therapy with (177)Lu-DOTATATE: low fraction of patients suitable for peptide receptor radionuclide therapy and evidence of chromogranin A level-positive neuroendocrine differentiation.
    Jois B; Asopa R; Basu S
    Clin Nucl Med; 2014 Jun; 39(6):505-10. PubMed ID: 24662668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
    Thapa P; Ranade R; Ostwal V; Shrikhande SV; Goel M; Basu S
    Nucl Med Commun; 2016 Oct; 37(10):1030-7. PubMed ID: 27243215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prospective Observational Study to Evaluate the Effects of Long-Acting Somatostatin Analogs on
    Gålne A; Almquist H; Almquist M; Hindorf C; Ohlsson T; Nordenström E; Sundlöv A; Trägårdh E
    J Nucl Med; 2019 Dec; 60(12):1717-1723. PubMed ID: 31000584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.